Globally accredited

by leading regulatory agencies, including USFDA, EU, and more

About

Aizant Drug Research Solutions Pvt. Ltd.

Founded in 2008, Aizant Drug Research Solutions Pvt. Ltd. is a trusted global leader in Formulation Development, Contract Development and Manufacturing (CDMO), Contract Manufacturing (CMO), and Clinical Research (CRO) services, with a diverse product portfolio spanning multiple therapeutic areas and dosage forms. Building on this strong foundation, we have expanded our capabilities in API research and development (API R&D) to offer end-to-end solutions to our clients.

Digitally enabled global leader in the pharmaceutical industry, delivering innovative solutions that enhance patients’ quality of life.

Excellence through innovative science and technology, foster a collaborative and accountable team culture, and commit to responsible research that positively impacts communities and the environment.

Our Services

Development
Research & Development (R&D and CDMO)

Aizant provides comprehensive R&D and CDMO services that accelerate the development of pharmaceutical products. Our expertise spans the entire lifecycle, from formulation development and analytical testing to clinical studies and commercial-scale production.

Manufacturing
Contract Manufacturing Organization (CMO)

We offer a full range of contract manufacturing organization (CMO) services tailored to the diverse needs of the pharmaceutical industry, utilizing advanced technologies like hot melt extrusion, spray drying, and complex generics. Our facilities provide scalable, high-quality manufacturing solutions for clinical trial materials and commercial production.

Clinical Research

Our end-to-end clinical research services are tailored to meet the stringent needs of the pharmaceutical and biotechnology industries. With expertise in bioanalytical services, bioavailability/bioequivalence (BA/BE) studies, and clinical trial management, we ensure seamless execution of clinical programs.

Portfolio

Aizant develops high-quality, regulatory-compliant pharmaceutical products in diverse dosage forms for out-licensing opportunities in global markets. Our portfolio serves the US, Canada, Europe, and the Rest of the World (ROW), spanning a wide range of therapeutic categories, including cardiovascular, anticancer, antidiabetic, antiviral, antibiotics, and more.

Advancing API
Development with Purpose.

Built on a foundation of innovation and compliance, our API capabilities span route design, impurity profiling, and regulatory-ready development with a focused approach to oncology and other high-impact therapeutic areas across generics and NCEs.

Read More

Our Facilities

We are equipped with state-of-the-art infrastructure, offering a unique advantage by housing every stage of pharmaceutical development under one roof. From advanced R&D labs to clinical trial units and globally accredited manufacturing facilities, our seamless integration delivers high-quality solutions from research through to commercial production.

Marketing Plan

Manufacturing Facility

Our facilities offer scalable solutions for both clinical and commercial production, meeting the highest standards of quality control and efficiency.

Clinical Facility

With a 190-bed capacity, our clinical facility supports phase I-IV clinical trials, providing comprehensive, reliable research data for pharmaceutical development.

Formulation R&D Facility

Our advanced R&D labs are fully equipped for formulation development, analytical testing, and regulatory support, enabling us to provide flexible, cutting-edge solutions for complex drug development needs.

API R&D Facility

Our advanced API R&D centre in Modavalasa, Vizianagaram, is equipped with state-of-the-art chemical and analytical labs, oncology & HPAPI suites, and AI/ML-driven process systems. Designed with safety, sustainability, and regulatory excellence, it enables innovation in complex and high-potency API development.

Manufacturing Facility

Our facilities offer scalable solutions for both clinical and commercial production, meeting the highest standards of quality control and efficiency.

Clinical Facility

With a 190-bed capacity, our clinical facility supports phase I-IV clinical trials, providing comprehensive, reliable research data for pharmaceutical development.

Formulation R&D Facility

Our advanced R&D labs are fully equipped for formulation development, analytical testing, and regulatory support, enabling us to provide flexible, cutting-edge solutions for complex drug development needs.

API R&D Facility

Our advanced API R&D centre in Modavalasa, Vizianagaram, is equipped with state-of-the-art chemical and analytical labs, oncology & HPAPI suites, and AI/ML-driven process systems. Designed with safety, sustainability, and regulatory excellence, it enables innovation in complex and high-potency API development.

Feeding Futures. Supporting Communities.

Our responsibility extends beyond innovation and quality in drug research; it is our mission to contribute to the well-being of society and create meaningful changes in the lives of those in need.

Bringing Your Pharma Vision to Life.

Turning your pharmaceutical ideas into reality with end-to-end services from R&D to manufacturing.

    Knowledge Hub

    Discover the latest blogs, news, and events and stay informed with curated content.